Menu
GeneBe

PMEL

premelanosome protein

Basic information

Region (hg38): 12:55954104-55973317

Previous symbols: [ "SIL", "SILV" ]

Links

ENSG00000185664NCBI:6490OMIM:155550HGNC:10880Uniprot:P40967AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PMEL gene.

  • Inborn genetic diseases (15 variants)
  • not provided (12 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PMEL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
1
clinvar
4
missense
14
clinvar
1
clinvar
7
clinvar
22
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 14 4 8

Variants in PMEL

This is a list of pathogenic ClinVar variants found in the PMEL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-55954267-A-T not specified Uncertain significance (Feb 05, 2024)3215795
12-55954313-C-G not specified Uncertain significance (Sep 22, 2023)3215794
12-55954322-G-A Likely benign (Mar 29, 2018)737198
12-55954347-C-T not specified Uncertain significance (Mar 07, 2024)3215793
12-55955270-T-TTACCTATATATATATATA Benign (May 21, 2018)781077
12-55955337-A-G Benign (Jul 31, 2018)789321
12-55955344-C-T not specified Uncertain significance (Apr 28, 2022)2286718
12-55955547-C-A not specified Uncertain significance (Apr 04, 2023)2532744
12-55955821-C-T not specified Uncertain significance (Dec 20, 2021)2221121
12-55955822-C-T Benign (Jul 31, 2018)789322
12-55955823-G-A PMEL-related disorder Likely benign (Feb 21, 2023)789323
12-55955827-G-A not specified Uncertain significance (Jun 13, 2023)2521130
12-55955846-C-G not specified Uncertain significance (Aug 02, 2021)2240728
12-55956109-T-C not specified Uncertain significance (Oct 05, 2023)3215792
12-55956121-C-T not specified Uncertain significance (Jul 13, 2022)2382350
12-55956963-G-A Benign (Mar 29, 2018)713129
12-55957041-G-C not specified Uncertain significance (Aug 16, 2022)2406682
12-55957045-T-G not specified Uncertain significance (Apr 06, 2023)2533994
12-55957080-A-G not specified Likely benign (Sep 14, 2023)2589339
12-55957101-G-A not specified Uncertain significance (May 04, 2023)2569247
12-55957193-C-G Benign (Dec 31, 2019)769389
12-55957216-G-A Benign (May 30, 2018)790659
12-55957218-G-A Benign (Mar 01, 2018)787402
12-55957274-T-C Likely benign (Mar 28, 2018)739674
12-55957383-G-T not specified Uncertain significance (Nov 17, 2023)3215798

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PMELprotein_codingprotein_codingENST00000449260 1119213
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.06e-180.0088312559401541257480.000613
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8943223700.8690.00001864260
Missense in Polyphen123140.90.872971724
Synonymous-0.1321481461.010.000007471473
Loss of Function0.3102829.80.9390.00000153307

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001100.00110
Ashkenazi Jewish0.0008940.000893
East Asian0.0001090.000109
Finnish0.0001390.000139
European (Non-Finnish)0.0009160.000915
Middle Eastern0.0001090.000109
South Asian0.0003920.000392
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity. {ECO:0000269|PubMed:11694580, ECO:0000269|PubMed:21962903}.;

Recessive Scores

pRec
0.319

Intolerance Scores

loftool
rvis_EVS
-0.04
rvis_percentile_EVS
50.51

Haploinsufficiency Scores

pHI
0.530
hipred
N
hipred_score
0.123
ghis
0.395

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pmel
Phenotype
pigmentation phenotype; vision/eye phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
pmelb
Affected structure
retinal pigmented epithelium
Phenotype tag
abnormal
Phenotype quality
morphology

Gene ontology

Biological process
melanosome organization;melanin biosynthetic process
Cellular component
extracellular region;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;integral component of plasma membrane;multivesicular body membrane;melanosome
Molecular function
protein binding;identical protein binding